pharma
dog
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
News
when
Latest
Archive
by source
All Sources
Sources Page
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
396
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Marketed
gentamicin sulfate
Gentamicin Sulfate
Bacterial Blepharoconjunctivitis
Fera Pharmaceuticals LLC
Marketed
grass pollen [cocksfoot (Dactylis glomerata) + sweet vernal (Anthoxanthum odoratum) + rye (Lolium perenne) + meadow (Poa pratensis) + timothy (Phleum pratense)] allergen extract
Oralair
Grass Pollen Allergy
Greer Laboratories Inc
Marketed
guaifenesin
Elixsure EX (guaifenesin)
Cough
Moberg Pharma AB
← prev
page 11 of 14
next →
Pain
89
Neurology
1
Phase 2
ifenprodil
ifenprodil [INN]
Chronic Cough
Seyltx Inc
Phase 2
ifetroban
Dyscorban (ifetroban)
Duchenne Muscular Dystrophy
$CPIX
CUMBERLAND PHARMACEUTICALS INC
Preclinical
incyclinide
incyclinide
Acute Lung Injury
CMTx Biotech Inc
Marketed
ipratropium bromide
Ipratropium Bromide
Chronic Bronchitis
The Ritedose Corp
Phase 3
itepekimab
itepekimab
Chronic Obstructive Pulmonary Disease (COPD)
$REGN
REGENERON PHARMACEUTICALS, INC.
Preclinical
kynurenic acid
Idiopathic Pulmonary Fibrosis
BirchBioMed Inc
Marketed
lefamulin acetate
Xenleta (lefamulin acetate)
Community-Acquired Bacterial Pneumonia
Nabriva Therapeutics US Inc
Marketed
levalbuterol hydrochloride
Levalbuterol Hydrochloride
Bronchospasm
The Ritedose Corp
Marketed
levalbuterol tartrate
Xopenex HFA (levalbuterol tartrate)
Bronchospasm
Lupin Ltd
Marketed
levofloxacin
Levofloxacin
Acute Bacterial Sinusitis
Teva Pharmaceuticals USA Inc
Marketed
lincomycin
Lincomycin
Enteritis
Micro Labs USA Inc
Marketed
lincomycin hydrochloride
Lincomycin Hydrochloride
Bacterial Endocarditis
GeneYork Pharmaceuticals Group LLC
Marketed
linezolid
Linezolid
Diabetic Foot Infection (DFI)
HQ Speciality Pharma
Phase 1
lixumistat
lixumistat [INN]
Pancreatic Ductal Adenocarcinoma
Immunomet Therapeutics Inc
Marketed
loratadine
Loratadine
Allergic Rhinitis
Guardian Drug Company Inc
pre_registration
lorundrostat hydrobromide
lorundrostat hydrobromide
Hypertension
$MLYS
Mineralys Therapeutics, Inc.
Phase 2
luvomeran
luvomeran
Cystic Fibrosis
$VERX
Vertex, Inc.
Marketed
mannitol
Bronchitol (mannitol)
Cystic Fibrosis
Arna Pharma Pty Ltd
Phase 2
mecasermin rinfabate
mecasermin rinfabate
Bronchopulmonary Dysplasia
Chiesi Farmaceutici SpA
Marketed
mepolizumab
Nucala (mepolizumab)
Eosinophilic Granulomatosis with Polyangiitis (Churg-Stra…
GlaxoSmithKline LLC
Marketed
metaproterenol sulfate
Metaproterenol Sulfate
Asthma
Chartwell Pharmaceuticals LLC
Marketed
modafinil
Modafinil
Obstructive Sleep Apnea
Appco Pharma LLC
pre_registration
molgramostim
Molbreevi (molgramostim)
Lung Disease
$SVRA
Savara Inc
Marketed
montelukast sodium
Montelukast Sodium
Chronic Asthma
Senores Pharmaceuticals Inc
Marketed
nafcillin sodium
Nafcillin Sodium
Bacterial Endocarditis
Claris Lifesciences Inc
Phase 2
nemonoxacin
Taigexyn (nemonoxacin [INN])
Diabetic Foot Infection (DFI)
TaiGen Biotechnology Co Ltd
Phase 3
nintedanib
NINTEDANIB
Pterygium
Cloudbreak Therapeutics LLC
